Crux Biomedical implants 1st anti-embolism filter in U.S.

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Crux Biomedical, a medical device firm, has announced that it successfully completed the first implant of the Crux IVC Filter in the United States.

The filter, used to prevent a pulmonary embolism, was implanted at the Atlanta Medical Center by David Rosenthal, MD, chief of vascular surgery. Retrievable IVC filters were first introduced to the U.S. market in 2002.

Annual U.S. sales of IVC filter are estimated to be $252 million in 2008, according to the Portola Valley, Calif.-based company. The firm said its filter design provides self-centering, ease of retrieval and low profile.